Agile Therapeutics
AGRX
$0.36
Share price
-0.82%
Change (1 day)
-90.30%
Change (1 year)
Categories
P/S ratio for Agile Therapeutics (AGRX)
P/S ratio as of June 2024 (TTM): 0.1161
According to Agile Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.116105. At the end of 2023 the company had a P/S ratio of 0.2500.
P/S ratio history for Agile Therapeutics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.2500 | -70.49% |
| 2022 | 0.8470 | -94.14% |
| 2021 | 14.4 | -95.69% |
| 2020 | 335 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.90 | 3,258.76% | 🇺🇸 USA |
 Pfizer PFE | 2.90 | 2,398.18% | 🇺🇸 USA |
 Merck MRK | 5.19 | 4,372.95% | 🇺🇸 USA |
 TherapeuticsMD TXMD | 22.6 | 19,355.06% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |